Sandoz Malaysia Disrupts NHL and RA Treatment L...
Sandoz Malaysia has partnered with Alpro Pharmacy to launch the first biosimilar treatment for Non-Hodgkin Lymphoma (NHL) and Rheumatoid Arthritis (RA) patients in Malaysia. This strategic collaboration, formalised through a...
New: Sandoz Brings Biosimilar Treatment through...
Partnership integrates Sandoz biosimilars into Alpro Pharmacy’s OncoHelp programme to support patients from government hospitals with Non-Hodgkin Lymphoma (NHL) and Rheumatoid Arthritis (RA) Collaboration broadens treatment pathways for NHL and...
Sandoz Launches First Biosimilar via Alpro Onco...
Collaboration broadens treatment pathways for NHL and RA patients through access to quality-assured biosimilar medicines Initiative reinforces a shared commitment by Sandoz and Alpro Pharmacy to improve continuity of care...
Sandoz & Alpro Pharmacy Jalin Kerjasama, Perken...
Sandoz, peneraju global ubat-ubatan mampu milik, dan Alpro Pharmacy, rangkaian farmasi preskripsi terkemuka di Malaysia, hari ini memeterai perjanjian strategik untuk meningkatkan akses pesakit kepada rawatan berkualiti tinggi bagi penyakit...
Inisiatif baru Sandoz Malaysia dan Alpro Pharma...
Dalam sistem penjagaan kesihatan tradisional, hospital selama ini menjadi pusat utama bagi rawatan penyakit serius seperti kanser dan penyakit autoimun kronik. Namun ekosistem penjagaan kesihatan di Malaysia kini menunjukkan perubahan...
